Pressure Muscle Index and Threshold of Over-assistance During Pressure Support Ventilation
PUMA
PressUre-Muscle-index to Identify Patient's Desired Tidal Volume and the Threshold of Over-Assistance During Pressure Support Ventilation
1 other identifier
observational
20
1 country
1
Brief Summary
Pressure support ventilation (PSV) is used to assist the breathing of the intubated patient with some pressure from the ventilator. This support aims at avoiding excessive inspiratory effort, while ensuring a certain degree of training of the patient's inspiratory muscle. Avoiding both minimal and excessive assistance is thus important for the optimal care of the intubated patient ensuring a lung and diaphragm protective ventilation with the goal to liberate the patient from the ventilator as soon as possible. Recently pressure-muscle-index (PMI), an index of inspiratory effort easy to be measured on the ventilator screen, has been proposed to avoid excessive assistance in PSV. This will be the first prospective study testing the effects of setting pressure support based on PMI to avoid excessive assistance on patients recovering from acute lung injury (acute hypoxemic respiratory failure).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2024
CompletedFirst Posted
Study publicly available on registry
July 10, 2024
CompletedStudy Start
First participant enrolled
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedMay 20, 2025
August 1, 2024
1.4 years
July 2, 2024
May 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Inspiratory Occlusion
To investigate the role of the inspiratory occlusion as a diagnostic tool to understand the patient's desired tidal volume and minute ventilation in Pressure Support Ventilation (PSV),
60 minutes
Pressure Muscle Index (PMI)
To investigate the role of a PMI\>0 strategy to avoid over-assistance in Pressure Support Ventilation
60 minutes
Secondary Outcomes (2)
Pendelluft
60 minutes
Lung and Diaphragm Protective Ventilation
60 minutes
Interventions
First, for each patient enrolled we will perform inspiratory and expiratory occlusions - routinely performed diagnostic maneuvers to measure patient's breathing effort - at the clinically set level of breathing assistance by the mechanical ventilator. Importantly, we will measure pressure-muscle-index (PMI). Second, we will set the level of assistance (i.e. pressure support, PS) in order to make PMI=0. The PS level at which PMI=0 (PS PMI=0) will be used as reference for the study protocol. After 5 minutes at PS PMI=0 we will perform inspiratory and expiratory occlusions.
3 steps of PS above (+2, +4, +6 cmH2O) and 3 below (-2, -4, -6 cmH2O) PSPMI=0 done in a randomized order (sequence in envelopes opened blindly by the investigators). Each step will last ≤5 minutes if poorly tolerated (see tolerance rule in description). At the end of each step we will perform 1 inspiratory occlusion and 3 expiratory occlusions. Each of the expiratory occlusion will be separated by 30 seconds in order to restore the patient's breathing pattern. We will resume a 3-minutes clinical PS in between each step to minimize changes in PaCO2. If not yet comprised by the study steps each patient will undergo an adjunctive 5 minutes step at PS 0 (zero) cmH2O.
Eligibility Criteria
The Study population will include patients mechanically ventilated in the St. Michael's Intensive Care Unit. Patients who are younger than 18 years of age will be excluded from this study on the basis that the ICUs at St. Michael's Hospital are intended for adults; individuals aged less than 18 years are rarely, if ever, admitted.
You may qualify if:
- \>18 y.o.
- Invasively ventilated in Intensive Care Unit.
- Diagnosed with acute hypoxemic respiratory failure (P/F\<300 mmHg).
- Breathing on pressure support ventilation.
You may not qualify if:
- \<18 y.o.
- Contraindication for Electrical Impedence Tomography monitoring (e.g. pacemaker, burns, or - wounds limiting electrode placement).
- Severe and previously diagnosed neurological and neuromuscular disease.
- Psychomotor agitation (Sedation Agitation Scale \> 4).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurent Brochard
Unity Health Toronto - St. Michael's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2024
First Posted
July 10, 2024
Study Start
October 4, 2024
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
May 20, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share